Oral swab (baseline) | Oral swab (follow-up) | Anal swab (baseline) | Anal swab (follow-up) | |||||
---|---|---|---|---|---|---|---|---|
Positives | 27 | 20.1% | 23 | 21.3% | 147 | 88.6% | 101 | 86.3% |
Genotyped | 18 | 66.7% | 19 | 82.6% | 112 | 76.2% | 70 | 69.3% |
High-Risk | 2 | 11.1% | 7 | 36.8% | 27 | 24.1% | 11 | 15.7% |
Low-risk | 12 | 66.6% | 5 | 26.3% | 65 | 58% | 49 | 70% |
Negatives | 107 | 79.9% | 85 | 78.7% | 19 | 11.4% | 16 | 13.7% |
Total evaluable specimens | 134 | 108 | 166 | 117 | ||||
Invalid Samples* | 32 | 19% | 9 | 7.7% | 0 | 0 |